High-Precision radiation blitz tested to control widespread cancer

NCT ID NCT05717166

Recruiting now Disease control Sponsor: David Palma Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding a highly focused, high-dose radiation treatment (called SABR) to standard cancer care can help people whose cancer has spread to up to 10 other sites in the body. It will compare survival and quality of life between patients who receive standard care alone and those who receive standard care plus SABR to all known tumors. The goal is to see if aggressively targeting all visible cancer sites can better control the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

BC Cancer - Centre for the North
NOT_YET_RECRUITING

Prince George, British Columbia, V2M 7E9, Canada

Contact
BC Cancer - Vancouver
RECRUITING

Vancouver, British Columbia, V5Z 4C2, Canada

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Centre Hospitalier de l'Université de Montréal-CHUM
RECRUITING

Montreal, Quebec, H2X 0C1, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
London Regional Cancer Program of the Lawson Health Research Institute
RECRUITING

London, Ontario, N6A 5W9, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Universitätsspital Zürich
RECRUITING

Zurich, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

METASTATIC TUMOR